Silymarin Constituents Enhance ABCA1 Expression in THP-1 Macrophages
Tóm tắt
Từ khóa
Tài liệu tham khảo
Atanasov, 2015, Discovery and resupply of pharmacologically active plant-derived natural products: A review, Biotechnol. Adv., 33, 1582, 10.1016/j.biotechadv.2015.08.001
Kvasnicka, 2003, Analysis of the active components of silymarin, J. Chromatogr. A, 990, 239, 10.1016/S0021-9673(02)01971-4
Gazak, 2007, Silybin and silymarin—New and emerging applications in medicine, Curr. Med. Chem., 14, 315, 10.2174/092986707779941159
Weidmann, 2012, Dihydroquercetin: More than just an impurity?, Eur. J. Pharmacol., 684, 19, 10.1016/j.ejphar.2012.03.035
Lee, 2003, Molecular structure and stereochemistry of silybin a, silybin b, isosilybin a, and isosilybin b, isolated from silybum marianum (milk thistle), J. Nat. Prod., 66, 1171, 10.1021/np030163b
Saller, 2001, The use of silymarin in the treatment of liver diseases, Drugs, 61, 2035, 10.2165/00003495-200161140-00003
Skottova, 1998, Silymarin as a potential hypocholesterolaemic drug, Physiol. Res., 47, 1
Krecman, 1998, Silymarin inhibits the development of diet-induced hypercholesterolemia in rats, Planta Med., 64, 138, 10.1055/s-2006-957391
Skottova, 2003, Effects of polyphenolic fraction of silymarin on lipoprotein profile in rats fed cholesterol-rich diets, Pharmacol. Res., 47, 17, 10.1016/S1043-6618(02)00252-9
Sobolova, 2006, Effect of silymarin and its polyphenolic fraction on cholesterol absorption in rats, Pharmacol. Res., 53, 104, 10.1016/j.phrs.2005.09.004
Fried, 2012, Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis c unsuccessfully treated with interferon therapy: A randomized controlled trial, JAMA, 308, 274, 10.1001/jama.2012.8265
Oram, 2001, Abca1: The gatekeeper for eliminating excess tissue cholesterol, J. Lipid Res., 42, 1173, 10.1016/S0022-2275(20)31566-2
Oram, 2000, Tangier disease and abca1, BBA Mol. Cell Biol. Lipids, 1529, 321, 10.1016/S1388-1981(00)00157-8
Clee, 2002, Association between increased arterial-wall thickness and impairment in abca1-driven cholesterol efflux: An observational study, Lancet, 359, 37, 10.1016/S0140-6736(02)07277-X
Phillips, 2014, Molecular mechanisms of cellular cholesterol efflux, J. Biol. Chem., 289, 24020, 10.1074/jbc.R114.583658
Chawla, 2001, A ppar gamma-lxr-abca1 pathway in macrophages is involved in cholesterol efflux and atherogenesis, Mol. Cell, 7, 161, 10.1016/S1097-2765(01)00164-2
Atanasov, 2014, Identification of isosilybin a from milk thistle seeds as an agonist of peroxisome proliferator-activated receptor gamma, J. Nat. Prod., 77, 842, 10.1021/np400943b
Wang, 2014, Natural product agonists of peroxisome proliferator-activated receptor gamma (ppar-gamma): A review, Biochem. Pharmacol., 92, 73, 10.1016/j.bcp.2014.07.018
Wilson, 2000, Investigation of the alamar blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity, Eur. J. Biochem., 267, 5421, 10.1046/j.1432-1327.2000.01606.x
Ladurner, 2012, 2-(2,4-dihydroxyphenyl)-5-(E)-propenylbenzofuran promotes endothelial nitric oxide synthase activity in human endothelial cells, Biochem. Pharmacol., 84, 804, 10.1016/j.bcp.2012.06.029